Detalhe da pesquisa
1.
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.
Lancet Infect Dis
; 24(3): 285-296, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012890